Literature DB >> 504658

Radiation absorbed dose to the lens in dacryoscintigraphy with 99mTcO4-.

J S Robertson, M L Brown, D M Colvard.   

Abstract

Calculations of the radiation dose to the lens for 99mTcO4- in dacryoscintigraphy are developed in some detail. The results indicate that the absorbed dose to the germinal epithelium of the lens is 2.2 X 10(-5) to 1.4 X 10(-4) rad/microCi (5.9 x 10(-12) to 3.8 x 10(-11) Gy/Bq) 99mTcO4- under physiological conditions. With blockage of the lacrimal drainage apparatus, the dose to the lens could increase to 4 X 10(-3) rad/microCi (1 X 10(-9) Gy/Bq).

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 504658     DOI: 10.1148/133.3.747

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  5 in total

1.  MR dacryocystography: comparison with dacryocystography and CT dacryocystography.

Authors:  L Manfrè; M de Maria; E Todaro; A Mangiameli; F Ponte; R Lagalla
Journal:  AJNR Am J Neuroradiol       Date:  2000 Jun-Jul       Impact factor: 3.825

2.  Magnetic resonance imaging in the pre-operative evaluation of obstructive epiphora: true-FISP and VIBE vs gadolinium.

Authors:  Francesco Somma; Vincenzo d'Agostino; Fabio Tortora; Nicola Serra; Gerardo Sorrentino; Valeria Piscitelli; Andrea Somma; Mario Gamerra
Journal:  Radiol Med       Date:  2016-11-05       Impact factor: 3.469

3.  MR dacryocystography in the evaluation of patients with obstructive epiphora treated by means of interventional radiologic procedures.

Authors:  B Coskun; E Ilgit; B Onal; O Konuk; G Erbas
Journal:  AJNR Am J Neuroradiol       Date:  2011-12-15       Impact factor: 3.825

4.  [Presaccal stenosis as a cause of epiphora].

Authors:  M Lüchtenberg; J Berkefeld; A Bink
Journal:  Radiologe       Date:  2008-12       Impact factor: 0.635

5.  Lacrimal scintigraphy. II. Its role in the diagnosis of epiphora.

Authors:  L A Amanat; T E Hilditch; C S Kwok
Journal:  Br J Ophthalmol       Date:  1983-11       Impact factor: 4.638

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.